About: Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific journal article

Attributes	Values
rdf:type	Item
description	artículu científicu espublizáu en 1996 (ast) vědecký článek publikovaný v roce 1996 (cs) 1996 թվականի դեկտեմբերին հրատարակված գիտական հոդված (hy) наукова стаття, опублікована в грудні 1996 (uk) 1996 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած (hyw) 1996年學術文章 (zh) vedecký článok (publikovaný 1996/12/10) (sk) مقالة علمية (نشرت في 10-12-1996) (ar) article publié dans les Proceedings of the National Academy of Sciences of the United States of America (fr) scientific journal article (en) im Dezember 1996 veröffentlichter wissenschaftlicher Artikel (de) wetenschappelijk artikel (gepubliceerd op 1996/12/10) (nl)
publication date	wds:Q28586230-0589E0C9-32E1-4A86-A1E6-8D39853F9D3E
publication date	1996-12-10 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q28586230-F0CA9720-DB88-4D99-BFEF-DA750F923B72
language of work or name	English
cites work	wds:Q28586230-0F1BD594-8367-4DC7-A074-CC17B54A5E74 wds:Q28586230-0FEF4C86-E7F0-47EB-A211-88AD3E5F615A wds:Q28586230-15D736D7-4651-41C4-800A-E7D67C61C9A3 wds:Q28586230-3391FECE-F849-4431-BC94-BBD309A1C390 wds:Q28586230-4B906F2B-AE3C-4CBA-B9DC-34CBF9FA05D2 wds:Q28586230-5A385802-BBEE-4FBB-8E52-CBBA99E25ED1 wds:Q28586230-6585B94D-0882-4C3D-87C0-CB38A4AE184F wds:Q28586230-6999C2D4-A815-44CA-90A0-A8AD2E68108C wds:Q28586230-6A7D896E-2D39-4A85-BA85-6B65A93DA0E1 wds:Q28586230-7084D7E7-797B-4A53-AB90-953E9FF2CAAF wds:Q28586230-7311DA90-1D22-4037-B69C-DDA34CB8C9EF wds:Q28586230-745881D5-0533-4CE6-8DD6-03724478D7FC wds:Q28586230-8C7D9AFB-F06C-4F18-9A76-4E39E303E9FA wds:Q28586230-912AFDCF-BDB9-485A-9BA4-8FE0F091953D wds:Q28586230-92725531-E0D9-4800-862B-D70D00DDF2D9 wds:Q28586230-92B32BBE-697B-4490-BCA5-5C8E76F51D24 wds:Q28586230-A613E5FB-AC77-46B5-B582-6B0E2226D744 wds:Q28586230-B1689B23-B49F-43F2-BE3C-50755A2187A4 wds:Q28586230-B3BBA005-8538-48AB-B3C2-74BEA62041EC wds:Q28586230-B5C2CF0A-F474-49EF-B989-8661BBAE0190 wds:Q28586230-B722DFDA-ADB8-440D-903B-5BB5B3010F07 wds:Q28586230-BE64AAA0-C6B0-4B5F-AE02-DCAC5E1B6254 wds:Q28586230-C173A86F-387E-466C-BB76-C69E54EE7708 wds:Q28586230-C1D47EE3-1582-4527-A0D9-43D8AACE2816 wds:Q28586230-CA925186-97EC-4438-9273-E6AFEC963A5A wds:Q28586230-CDA8D9F3-9F9B-4F49-AF96-68B118988A6A wds:Q28586230-D2E55B94-D06A-4ABF-AAD8-ADA85BECDCC8 wds:Q28586230-E9AAFD80-7A5E-4B28-856F-A478A86CBEA0 wds:Q28586230-EF9CF442-C9CE-4AAC-A220-25294CEDE628 wds:Q28586230-EFC09FC7-80D3-4ADE-88AB-8287907A068A wds:Q28586230-F317213D-FDB5-4F90-8C4E-1A0BED11E5CF wds:Q28586230-F5A35B56-0548-43BA-A7FE-E31DF4A41328 wds:Q28586230-F5B210E8-D332-46B1-8CDA-4061CBA78D11 wds:Q28586230-F67AEDFC-BE98-435E-8540-B266B0C0A2F6
cites work	In vitro modulation of the apolipoprotein composition of high density lipoprotein. Displacement of apolipoprotein A-I from high density lipoprotein by apolipoprotein A-II Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. Role of insulin resistance in human disease (syndrome X): an expanded definition Nondenaturing polyacrylamide gradient gel electrophoresis Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism. Studies in transgenic mice Plasma high density lipoproteins. Metabolism and relationship to atherogenesis Expression of human apolipoprotein A-II and its effect on high density lipoproteins in transgenic mice Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice Apolipoprotein A-I containing lipoproteins in coronary artery disease Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II. Activation of the enzymic activity of hepatic lipase by apolipoprotein A-II. Characterization of a major component of high density lipoprotein as the activating plasma component in vitro Isolation, properties, and mechanism of in vitro action of lecithin: cholesterol acyltransferase from human plasma Characterization of human high-density lipoproteins by gradient gel electrophoresis High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis Functional lecithin:cholesterol acyltransferase deficiency and high density lipoprotein deficiency in transgenic mice overexpressing human apolipoprotein A-II Evidence for linkage of the apolipoprotein A-II locus to plasma apolipoprotein A-II and free fatty acid levels in mice and humans Protein composition determines the anti-atherogenic properties of HDL in transgenic mice The theory of tracer experiments with 131I-labelled plasma proteins Influence of mouse apolipoprotein A-II on plasma lipoproteins in transgenic mice A splice-junction mutation responsible for familial apolipoprotein A-II deficiency Apolipoprotein A-I is required for cholesteryl ester accumulation in steroidogenic cells and for normal adrenal steroid production High density lipoprotein metabolism. Marked reduction of high density lipoprotein cholesterol in mice genetically modified to lack apolipoprotein A-I Delayed catabolism of high density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiency Cholesterol efflux, cholesterol esterification, and cholesteryl ester transfer by LpA-I and LpA-I/A-II in native plasma Changes in the size of reconstituted high density lipoproteins during incubation with cholesteryl ester transfer protein: the role of apolipoproteins Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distri Mechanism of inhibition of hepatic triglyceride lipase from human postheparin plasma by apolipoproteins A-I and A-II Influence of apolipoprotein composition of high density lipoprotein particles on cholesteryl ester transfer protein activity. Particles containing various proportions of apolipoproteins AI and AII Hepatic lipase hydrolysis of lipid monolayers. Regulation by apolipoproteins Structural organization of the gene encoding apolipoprotein A-II in an amyloidotic strain of senescence-accelerated mouse
author name string	wds:Q28586230-90F93022-A53C-4F0C-8B4E-3F84F0F3C559 wds:Q28586230-CE756F41-BCAF-488E-9206-516150D00AE0
OpenCitations bibliographic resource ID	wds:Q28586230-1834D45F-E945-4033-BFE3-40344FA885EB
OpenCitations bibliographic resource ID	https://w3id.org/oc/corpus/br/4648885
author name string	J. L. Breslow W. Weng
OpenCitations bibliographic resource ID	4648885
rdfs:label	Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility (en) Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility (nl) Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility (ast)
skos:prefLabel	Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility (en) Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility (nl) Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility (ast)
name	Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility (en) Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility (nl)

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 195 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software